BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VTIMEZONE TZID:Central Standard Time X-LIC-LOCATION:America/Chicago BEGIN:STANDARD DTSTART:20241103T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11 TZNAME:CST TZOFFSETFROM:-0500 TZOFFSETTO:-0600 END:STANDARD BEGIN:DAYLIGHT DTSTART:20250309T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3 TZNAME:CDT TZOFFSETFROM:-0600 TZOFFSETTO:-0500 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:2026 Annual Meeting by the Âé¶¹´«Ã½Ó³»­\n\nTi tle: Industry Therapeutic Update From Alexion\, AstraZeneca Rare Disease: From Pathophysiology to Practice-Expert Perspectives on C5 Inhibition in Anti-AChR Antibody-Positive gMG\n\nAccess URL: /msa/P ublic/Events/GetEventURL/23122\n\nLearn More About This Event: https://ww w.aan.com/msa/Public/Events/Details/23122 DTEND;TZID=Central Standard Time:20260421T124500 DTSTAMP:20260429T022137Z DTSTART;TZID=Central Standard Time:20260421T114500 LOCATION:McCormick Place West | W474 SEQUENCE:0 SUMMARY:Âé¶¹´«Ã½Ó³»­: Industry Therapeutic Update From Alexion\, AstraZeneca Rare D isease: From Pathophysiology to Practice-Expert Perspectives on C5 Inhibi tion in Anti-AChR Antibody-Positive gMG UID:fa18b414-3ed1-4f00-a91c-5b9c34c6c658 END:VEVENT END:VCALENDAR